Objective: To observe the effect of treatment with theophylline extended-release tablets in patients with bronchial asthma. Methods: The medical records of 76 asthma patients admitted from 2020.8 to 2022.9 were extracted. 38 cases in the reference group received conventional basic treatment and 38 cases in the observation group received conventional + sodium theophylline glycinate treatment, and the condition control of the patients in the two groups was compared. Results: The patients in the observation group all disappeared from the disease symptoms earlier than the reference group (P < 0.05). In terms of total effective rate, the difference between the reference group and the observation group was 65.79% vs 92.11% (P < 0.05). Conclusion: Oral treatment with sodium theophylline glycinate is recommended for asthma patients to better control their condition
